Hemophilia CANEXTions: Novel Therapies Access Summit
Gene therapies represent an exciting future for an increasing number of rare, expensive and difficult-to-treat medical conditions. Gene therapy for hemophilia is at the forefront of this wave and will be a proving ground for new policies and financing models.
The Hemophilia CANEXTions Summit is for policy makers, public and private health plans, specialty health centers, advocates from the patient community, health systems and healthcare providers, and novel therapy innovators to examine gene therapy and its potential impact on California’s health care system, as well as address potential barriers to patient access to gene therapy.
SAVE THE DATE!
- Tuesday, November 17th
- 8:30 AM – 12:15 PM
- Virtual Summit
Registration opens soon. Sign up for our Interest List Here to be notified as soon as registration begins.